Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frishman

Showing results (331-340 of 1,860) with videos related to

Pageof 186
Sort By:
Cardiology in Review|March 22, 2023
Cardiac Myosin Activator Omecamtiv Mecarbil: Novel Treatment for Systolic Heart FailureMaat Mack, William H Frishman
Journal of Minimally Invasive Gynecology|July 21, 2025
Who is in the OR Today?Meenal Misal, Gary N Frishman
Cardiology in Review|September 24, 2025
A Review of Venous Thromboembolism Risk, Assessment, and Prophylaxis in Aesthetic Plastic SurgeryTobias Whitford, William H Frishman
Cardiology in Review|July 1, 2025
Transthyretin Amyloid Cardiomyopathy: A Review of Approved PharmacotherapiesMohammed Kallash, William H Frishman
Cardiology in Review|December 3, 2025
Fluid Resuscitation In The Setting Of Sepsis-Induced HypotensionAlbert Zottola, William H Frishman
Cardiology in Review|February 6, 2025
Trimetazidine Use in Cardiovascular DiseaseMohammed Kallash, William H Frishman
Cardiology in Review|January 17, 2024
Thrombotic and Vascular Complications of Oral ContraceptivesStephen Windisch, William H Frishman
Cardiology in Review|October 8, 2010
Liver x receptors: a potential therapeutic target for modulating the atherosclerotic processNeil Parikh, William H Frishman
Journal of Clinical Pharmacology|May 20, 1998
Innovative drug treatments for viral and autoimmune myocarditisS Anandasabapathy, W H Frishman
Cardiology in Review|May 9, 2023
Teplizumab Therapy to Delay the Onset of Type 1 DiabetesJoel Novograd, William H Frishman
Pageof 186

Showing results (331-340 of 1,860) with videos related to

Sort By:
Pageof 186
Cardiology in Review|March 22, 2023
Cardiac Myosin Activator Omecamtiv Mecarbil: Novel Treatment for Systolic Heart FailureMaat Mack, William H Frishman
Journal of Minimally Invasive Gynecology|July 21, 2025
Who is in the OR Today?Meenal Misal, Gary N Frishman
Cardiology in Review|September 24, 2025
A Review of Venous Thromboembolism Risk, Assessment, and Prophylaxis in Aesthetic Plastic SurgeryTobias Whitford, William H Frishman
Cardiology in Review|July 1, 2025
Transthyretin Amyloid Cardiomyopathy: A Review of Approved PharmacotherapiesMohammed Kallash, William H Frishman
Cardiology in Review|December 3, 2025
Fluid Resuscitation In The Setting Of Sepsis-Induced HypotensionAlbert Zottola, William H Frishman
Cardiology in Review|February 6, 2025
Trimetazidine Use in Cardiovascular DiseaseMohammed Kallash, William H Frishman
Cardiology in Review|January 17, 2024
Thrombotic and Vascular Complications of Oral ContraceptivesStephen Windisch, William H Frishman
Cardiology in Review|October 8, 2010
Liver x receptors: a potential therapeutic target for modulating the atherosclerotic processNeil Parikh, William H Frishman
Journal of Clinical Pharmacology|May 20, 1998
Innovative drug treatments for viral and autoimmune myocarditisS Anandasabapathy, W H Frishman
Cardiology in Review|May 9, 2023
Teplizumab Therapy to Delay the Onset of Type 1 DiabetesJoel Novograd, William H Frishman
Pageof 186